Cargando…
Protection of the heart by treatment with a divalent-copper-selective chelator reveals a novel mechanism underlying cardiomyopathy in diabetic rats
BACKGROUND: Intracellular calcium (Ca(2+)) coordinates the cardiac contraction cycle and is dysregulated in diabetic cardiomyopathy. Treatment with triethylenetetramine (TETA), a divalent-copper-selective chelator, improves cardiac structure and function in patients and rats with diabetic cardiomyop...
Autores principales: | Zhang, Lin, Ward, Marie-Louise, Phillips, Anthony RJ, Zhang, Shaoping, Kennedy, John, Barry, Bernard, Cannell, Mark B, Cooper, Garth JS |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848860/ https://www.ncbi.nlm.nih.gov/pubmed/23981320 http://dx.doi.org/10.1186/1475-2840-12-123 |
Ejemplares similares
-
Diabetic cardiomyopathy is associated with defective myocellular copper regulation and both defects are rectified by divalent copper chelation
por: Zhang, Shaoping, et al.
Publicado: (2014) -
Altered Calcium Homeostasis Does Not Explain the Contractile Deficit of Diabetic Cardiomyopathy
por: Zhang, Lin, et al.
Publicado: (2008) -
Treatment with a copper-selective chelator causes substantive improvement in cardiac function of diabetic rats with left-ventricular impairment
por: Lu, Jun, et al.
Publicado: (2013) -
Copper chelation in patients with hypertrophic cardiomyopathy
por: Reid, Anna, et al.
Publicado: (2022) -
Antitrypanosomal 8-Hydroxy-Naphthyridines Are Chelators of Divalent Transition Metals
por: Wall, Richard J., et al.
Publicado: (2018)